LA-SER, Paris, France; Pharmacoepidemiology and Infectious Diseases Research Group, Pasteur Institute, Paris, France.
INSERM U657, University of Bordeaux Segalen, U657, Bordeaux, France.
PLoS One. 2014 Mar 19;9(3):e89990. doi: 10.1371/journal.pone.0089990. eCollection 2014.
Prescribing of antibiotics for upper respiratory tract infections (URTI) varies substantially in primary care.
To describe and compare antibiotic and antipyretic/anti-inflammatory drugs use, URTI symptoms' resolution and occurrence of potentially-associated infections in patients seeking care from general practitioners (GPs) who exclusively prescribe conventional medications (GP-CM), regularly prescribe homeopathy within a mixed practice (GP-Mx), or are certified homeopathic GPs (GP-Ho).
The EPI3 survey was a nationwide population-based study of a representative sample of 825 GPs and their patients in France (2007-2008). GP recruitment was stratified by self-declared homeopathic prescribing preferences. Adults and children with confirmed URTI were asked to participate in a standardized telephone interview at inclusion, one-, three- and twelve-month follow up. Study outcomes included medication consumption, URTI symptoms' resolution and potentially-associated infections (sinusitis or otitis media/externa) as reported by patients. Analyses included calibration to account for non-respondents and groups were compared using multivate analyses adjusting for baseline differences with a propensity score.
518 adults and children with URTI (79.3% rhinopharyngitis) were included (36.9% response rate comparable between groups). As opposed to GP-CM patients, patients in the GP-Ho group showed significantly lower consumption of antibiotics (Odds ratio (OR) = 0.43, 95% confidence interval (CI): 0.27-0.68) and antipyretic/anti-inflammatory drugs (OR = 0.54, 95% CI: 0.38-0.76) with similar evolution in related symptoms (OR = 1.16, 95% CI: 0.64-2.10). An excess of potentially-associated infections (OR = 1.70, 95% CI: 0.90-3.20) was observed in the GP-Ho group (not statistically significant). No difference was found between GP-CM and GP-Mx patients.
Patients who chose to consult GPs certified in homeopathy used less antibiotics and antipyretic/anti-inflammatory drugs for URTI than those seen by GPs prescribing conventional medications. No difference was observed in patients consulting GPs within mixed-practice. A non-statistically significant excess was estimated through modelling for associated infections in the GP-Ho group and needs to be further studied.
在初级保健中,针对上呼吸道感染(URTI)开具抗生素的情况差异很大。
描述和比较仅常规药物处方(GP-CM)、常规实践中定期开顺势疗法药物(GP-Mx)或经认证的顺势疗法医生(GP-Ho)的全科医生(GP)为寻求医疗服务的患者开具抗生素和退热/抗炎药物、URTI 症状缓解以及潜在相关感染的情况。
EPI3 调查是一项全国性的基于人群研究,对法国 825 名全科医生及其患者进行了代表性抽样(2007-2008 年)。根据自我报告的顺势疗法处方偏好对 GP 进行分层招募。确诊 URTI 的成年人和儿童被邀请在纳入时、一个月、三个月和十二个月随访时参加标准化电话访谈。研究结果包括患者报告的药物使用、URTI 症状缓解和潜在相关感染(鼻窦炎或中耳炎/外耳道炎)。分析包括校准以考虑未应答者,使用倾向评分调整基线差异的多变量分析比较组间差异。
纳入了 518 名患有 URTI 的成年人和儿童(79.3%为鼻咽炎)(36.9%的应答率在各组之间相当)。与 GP-CM 患者相比,GP-Ho 组患者抗生素(优势比(OR)=0.43,95%置信区间(CI):0.27-0.68)和退热/抗炎药物(OR=0.54,95%CI:0.38-0.76)的使用率明显较低,相关症状的演变也相似(OR=1.16,95%CI:0.64-2.10)。GP-Ho 组潜在相关感染(OR=1.70,95%CI:0.90-3.20)的发生率过高(无统计学意义)。GP-CM 和 GP-Mx 患者之间无差异。
选择咨询顺势疗法认证医生的患者比接受常规药物处方医生治疗的患者使用的抗生素和退热/抗炎药物更少。在混合实践中,患者咨询 GP 无差异。通过建模估计 GP-Ho 组相关感染的数量存在统计学意义,但需要进一步研究。